207 related articles for article (PubMed ID: 9323286)
1. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
Ekka BK; Bagga A; Srivastava RN
Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
3. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K; Parikh A; Webb H; Hothi D
Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
Hiraoka M; Tsukahara H; Matsubara K; Tsurusawa M; Takeda N; Haruki S; Hayashi S; Ohta K; Momoi T; Ohshima Y; Suganuma N; Mayumi M;
Am J Kidney Dis; 2003 Jun; 41(6):1155-62. PubMed ID: 12776266
[TBL] [Abstract][Full Text] [Related]
5. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D; Hari P; Sinha A; Pandey S; Bagga A
Clin J Am Soc Nephrol; 2021 Feb; 16(2):225-232. PubMed ID: 33478976
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
Cerkauskiene R; Kaltenis P
Medicina (Kaunas); 2005; 41 Suppl 1():26-30. PubMed ID: 15901972
[TBL] [Abstract][Full Text] [Related]
7. Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
Weerasooriya WALK; Abeyagunawardena AS; Thalgahagoda RS
Eur J Pediatr; 2023 Apr; 182(4):1741-1747. PubMed ID: 36757496
[TBL] [Abstract][Full Text] [Related]
8. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
10. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.
Gulati A; Sinha A; Sreenivas V; Math A; Hari P; Bagga A
Clin J Am Soc Nephrol; 2011 Jan; 6(1):63-9. PubMed ID: 20847092
[TBL] [Abstract][Full Text] [Related]
11. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.
Srivastava RN; Vasudev AS; Bagga A; Sunderam KR
Pediatr Nephrol; 1992 May; 6(3):247-50. PubMed ID: 1616833
[TBL] [Abstract][Full Text] [Related]
12. Single- versus Divided-Dose Prednisolone for the First Episode of Nephrotic Syndrome in Children: An Open-Label RCT.
Khan T; Akhtar S; Mukherjee D; Basu S; Tse Y; Sinha R
Clin J Am Soc Nephrol; 2023 Oct; 18(10):1294-1299. PubMed ID: 37335578
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
[TBL] [Abstract][Full Text] [Related]
14. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A; Saha A; Kumar M; Sharma S; Afzal K; Mehta A; Kalaivani M; Hari P; Bagga A
Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
[TBL] [Abstract][Full Text] [Related]
15. REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.
Schijvens AM; Dorresteijn EM; Roeleveld N; Ter Heine R; van Wijk JAE; Bouts AHM; Keijzer-Veen MG; van de Kar NCAJ; van den Heuvel LPWJ; Schreuder MF
BMJ Open; 2017 Sep; 7(9):e018148. PubMed ID: 28963315
[TBL] [Abstract][Full Text] [Related]
16. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
17. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
Sheikh S; Mishra K; Kumar M
Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS; Hindmarsh P; Trompeter RS
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[TBL] [Abstract][Full Text] [Related]
19. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M; Tsukahara H; Haruki S; Hayashi S; Takeda N; Miyagawa K; Okuhara K; Suehiro F; Ohshima Y; Mayumi M
Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
[TBL] [Abstract][Full Text] [Related]
20. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
Sinha A; Devi KG; Kalra S; Mani K; Hari P; Bagga A
Kidney Int; 2024 May; 105(5):1113-1123. PubMed ID: 38360110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
